Business Description
![Microbix Biosystems Inc Microbix Biosystems Inc logo](https://static.gurufocus.com/logos/0C00000I69.png?14)
Microbix Biosystems Inc
NAICS : 325414
SIC : 3741
ISIN : CA59501P1045
Description
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.92 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 1.06 | |||||
Interest Coverage | 1.51 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.98 | |||||
Beneish M-Score | -1.5 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.3 | |||||
3-Year EPS without NRI Growth Rate | 14.7 | |||||
3-Year FCF Growth Rate | -23.3 | |||||
3-Year Book Growth Rate | 43.4 | |||||
Future 3-5Y Total Revenue Growth Rate | 31.48 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 80.33 | |||||
9-Day RSI | 64.69 | |||||
14-Day RSI | 56.88 | |||||
6-1 Month Momentum % | -16.67 | |||||
12-1 Month Momentum % | -7.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.64 | |||||
Quick Ratio | 4.98 | |||||
Cash Ratio | 3.46 | |||||
Days Inventory | 207.83 | |||||
Days Sales Outstanding | 57.61 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8 | |||||
Shareholder Yield % | 0.45 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.38 | |||||
Operating Margin % | 5.75 | |||||
Net Margin % | 17.04 | |||||
FCF Margin % | 7.74 | |||||
ROE % | 16.16 | |||||
ROA % | 11.42 | |||||
ROIC % | 6.51 | |||||
ROC (Joel Greenblatt) % | 30.92 | |||||
ROCE % | 15.71 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 10.33 | |||||
Forward PE Ratio | 16 | |||||
PE Ratio without NRI | 10.33 | |||||
Price-to-Owner-Earnings | 11.92 | |||||
PS Ratio | 1.8 | |||||
PB Ratio | 1.53 | |||||
Price-to-Tangible-Book | 1.94 | |||||
Price-to-Free-Cash-Flow | 23.85 | |||||
Price-to-Operating-Cash-Flow | 15.5 | |||||
EV-to-EBIT | 7.9 | |||||
EV-to-EBITDA | 6.16 | |||||
EV-to-Revenue | 1.65 | |||||
EV-to-Forward-Revenue | 1.3 | |||||
EV-to-FCF | 19.75 | |||||
Price-to-Projected-FCF | 1.94 | |||||
Price-to-Median-PS-Value | 0.69 | |||||
Price-to-Graham-Number | 0.97 | |||||
Price-to-Net-Current-Asset-Value | 3 | |||||
Price-to-Net-Cash | 16.5 | |||||
Earnings Yield (Greenblatt) % | 12.67 | |||||
FCF Yield % | 4.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Microbix Biosystems Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 23.835 | ||
EPS (TTM) (C$) | 0.03 | ||
Beta | 0.72 | ||
Volatility % | 44.3 | ||
14-Day RSI | 56.88 | ||
14-Day ATR (C$) | 0.012895 | ||
20-Day SMA (C$) | 0.3175 | ||
12-1 Month Momentum % | -7.14 | ||
52-Week Range (C$) | 0.23 - 0.45 | ||
Shares Outstanding (Mil) | 137.42 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Microbix Biosystems Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Microbix Biosystems Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Microbix Biosystems Inc Frequently Asked Questions
What is Microbix Biosystems Inc(TSX:MBX)'s stock price today?
The current price of TSX:MBX is C$0.33. The 52 week high of TSX:MBX is C$0.45 and 52 week low is C$0.23.
When is next earnings date of Microbix Biosystems Inc(TSX:MBX)?
The next earnings date of Microbix Biosystems Inc(TSX:MBX) is .
Does Microbix Biosystems Inc(TSX:MBX) pay dividends? If so, how much?
Microbix Biosystems Inc(TSX:MBX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |